EcoDrugPlus

Ribosomal Protein S26

Ensembl ID : ENSPKIG00000007508
Gene Symbol: RPS26
3 Cross references
416 Possible Orthologues:

Ribosomal Protein S3a

Ensembl ID : ENSPKIG00000016856
Gene Symbol: RPS3A
4 Cross references
359 Possible Orthologues:

Ribosomal Protein S5

Ensembl ID : ENSPKIG00000011575
Gene Symbol: RPS5
3 Cross references
264 Possible Orthologues:

Ribosomal Protein S8

Ensembl ID : ENSPKIG00000010571
Gene Symbol: RPS8
3 Cross references
325 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSPKIG00000006794
Gene Symbol: RPSA
4 Cross references
516 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSPKIG00000016238
Gene Symbol: RPLP0
3 Cross references
398 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSPKIG00000019305
Gene Symbol: RPLP1
3 Cross references
382 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSPKIG00000016119
Gene Symbol: LOC111851638
3 Cross references
246 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSPKIG00000002045
Gene Symbol: SERPINC1
3 Cross references
201 Possible Orthologues:

Si:dkey-91m11.5

Ensembl ID : ENSPKIG00000006662
Gene Symbol: SI:DKEY-91M11.5
1 Cross references
133 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSPKIG00000022940
Gene Symbol: SIGMAR1
3 Cross references
205 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSPKIG00000008815
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).